MADRIGAL PHARMACEUTICALS, INC.·4

Feb 24, 5:09 PM ET

Levy Richard S 4

4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Feb 24, 2026

Insider Transaction Report

Form 4
Period: 2026-02-23
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-23$7.36/sh+2,500$18,40027,697 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1]
    2026-02-232,5000 total
    Exercise: $7.36Exp: 2026-08-11Common Stock (2,500 underlying)
Footnotes (1)
  • [F1]The shares underlying this option are fully vested and exercisable.
Signature
/s/ Mardi Dier, as Attorney-in-Fact|2026-02-24

Documents

1 file
  • 4
    wk-form4_1771970943.xmlPrimary

    FORM 4